Vote Scores
Filings read through

How funds voted at Paratek Pharmaceuticals, Inc.

Filers reporting
97, year to 30 June 2024
Latest meeting on file
Meetings on file
2

In the year to 30 June 2024, 97 filers on Form N-PX reported votes at Paratek Pharmaceuticals, Inc.. The votes fall in 2 meetings. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 395 marks to the ballot items, each with or against management. 74.4% of the marks are with management.

On say-on-pay, 19 of the 75 reporting filers that marked the item voted against management. This is 25.3% of the filers. Of the reported shares, 18.8% went against management. The median of the 3,781 companies on this site with a say-on-pay item is 7.5% of filers and 2.9% of reported shares.

At the meeting of 6 Jul 2023, 12 fund families have a say-on-pay position with management and 5 have a position against management.

By filers reporting in the year to 30 June 2024, Paratek Pharmaceuticals, Inc. was number 3,746 of 11,775 companies with a page and votes in that year. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 51.0% of the vote records at Paratek Pharmaceuticals, Inc.. At all companies on this site, it is 12.3%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 18 Sep 2023

86 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    5 vote records from 3 filers. 0 of the 2 filers that marked the item voted against management. 1 filer gave no management mark.

  2. Item 2: Advisory vote on pay tied to a merger or sale

    93 vote records from 79 filers. 54 of the 77 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 16 fund families
    • For 1
    • Against 15
    • Against management 15
  3. Item 3: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    18 vote records from 13 filers. 0 of the 13 filers that marked the item voted against management.

    • Positions of 8 fund families
    • For 8
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    4 vote records from 4 filers. 0 of the 4 filers that marked the item voted against management.

  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    4 vote records from 4 filers. 0 of the 4 filers that marked the item voted against management.

  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    40 vote records from 26 filers. 5 of the 26 filers that marked the item voted against management.

    • Positions of 9 fund families
    • For 8
    • Against 1
    • Against management 1

Positions of the fund families at the meeting of 18 Sep 2023

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Paratek Pharmaceuticals, Inc., meeting of 18 Sep 2023Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familyMerger pay
BairdAgainst, against management
BlackRock and iSharesAgainst, against management
BNY MellonAgainst, against management
Charles SchwabAgainst, against management
EquitableAgainst, against management
FidelityAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
John Hancock and ManulifeAgainst, against management
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
Northern Trust and FlexSharesAgainst, against management
PGIM and PrudentialAgainst, against management
SEIAgainst, against management
State Street and SPDRAgainst, against management
VanguardFor
Victory CapitalAgainst, against management

Every meeting on file

Meetings of Paratek Pharmaceuticals, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 20248660.0%
year to 30 June 202482725.3%

Say-on-pay, season by season

Say-on-pay at Paratek Pharmaceuticals, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 20249725.3%18.8%
Paratek Pharmaceuticals, Inc. and the median of companies on this site, year to 30 June 2024
Say-on-payThis companyMedian of companies on this site
Filers against management25.3%7.5%
Reported shares against management18.8%2.9%

The median covers 3,781 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Paratek Pharmaceuticals, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS10218.2%
SECTION 14A SAY-ON-PAY VOTES28551.0%
AUDIT-RELATED346.1%
EXTRAORDINARY TRANSACTIONS183.2%
CAPITAL STRUCTURE132.3%
COMPENSATION346.1%
CORPORATE GOVERNANCE7313.1%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Paratek Pharmaceuticals, Inc.. https://votescores.com/company/paratek-pharmaceuticals-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Paratek Pharmaceuticals, Inc. are on file?
2 meetings are on file, from 6 Jul 2023 to 18 Sep 2023. 2 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Paratek Pharmaceuticals, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2024. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Paratek Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Paratek Pharmaceuticals, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .